No Data
No Data
Sumitomo Mitsui Trust Asset Management increases its stake in Nabtesco(6268.JP) to 7.43%
On Nov 21, Sumitomo Mitsui Trust Asset Management and related parties submitted the Change Report to Ministry of Finance. The report shows that Sumitomo Mitsui Trust Asset Management and related
Japan Machinery Orders Decline 2.9% in September
Tokyu Family HD, OLC, etc. (additional) Rating
Downgrade - Bearish code stock name securities company conventional changes after -------------------------------------------------- <2175> SMSGS 'Buy' 'Hold' target stock price change code stock name securities company conventional changes after -------------------------------------------------- <1878> Daiwa Securities SMBC Nikko 17200 yen 18400 yen <2002> Nisshin
List of stocks with cleared clouds (Part 2) [Ichimoku Kinko Hyo: List of Stocks with Cleared Clouds]
○Under the cloud breakout stock list market Code Stock name Closing price Leading Span A Leading Span B Tokyo Stock Exchange main board <1429> Japan Aqua 785 879 790.5 <2282> Nippon Ham 4754 5417255 143.5 <2445> Takamiya 4384 47.75441.5 <3034> Quol HD 1347 1426.751362.5 <3099> Mitsukoshi Isetan 2216 2293.5
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of buying conversion brands Market Code Brand Name Closing Price SAR Tokyo Main Board <4527> Rohto Pharma 3443 3263 <4534> Mochida Pharma 3510 3355 <4536> Santen Pharma 1829 1733 <4552> JCR Pharma 6896 36 <4569> Kyorin Pharmaceuticals 1517 1468 <4574> Daiko Yakuhin 3903 73 <4611> Dainichi Paint 1026 1001 <4633> Sakata Inx
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-spons adr <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, and operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased to 47.8%, surpassing the same period last year by 0.8 points, due to cost reductions and improvements in product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. Positive evaluation for Takeda Pharmaceutical Co., Ltd. <4502> in the mid-term and Sony Corporation <7735>.
No Data
No Data